文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

通过为患有重叠慢性阻塞性肺疾病(COPD)的心血管疾病(CVD)患者建立特定于阿联酋的转诊算法来简化转诊流程:心脏病专家和肺病专家的合作成果。

Streamlining referrals by establishing a UAE-specific referral algorithm for CVD patients with overlapping COPD: a collaborative effort by cardiologists and pulmonologists.

作者信息

Shehab Abdulla, Alzaabi Ashraf, Al Zubaidi Abdulmajeed, Mahboub Bassam, Skouri Hadi, Alhameli Hamad, El-Tamimi Hassan, Iqbal Mohammed Nizam

机构信息

Department of Cardiology, Burjeel Hospital, Al Ain, United Arab Emirates.

Department of Pulmonology, Zayed Military Hospital, Abu Dhabi, United Arab Emirates.

出版信息

Front Cardiovasc Med. 2025 Jun 24;12:1531966. doi: 10.3389/fcvm.2025.1531966. eCollection 2025.


DOI:10.3389/fcvm.2025.1531966
PMID:40630897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12235745/
Abstract

INTRODUCTION: Concomitant COPD and CVD are highly prevalent and contribute to increased risk of hospitalizations, morbidity, and mortality, and impose a significant financial burden on healthcare systems. Diagnosis of COPD in patients with comorbid CVD and vice versa is challenging due to an overlap between the risk factors and symptoms of these two conditions. This 8-member task force comprising pulmonologists and cardiologists agreed that in the UAE, while COPD patients suspected of having CVD are promptly referred to cardiology, CVD patients who may potentially also have COPD are often not referred or referred late from cardiology to pulmonology. This gap in identifying CVD patients who may potentially also have COPD must be addressed to facilitate referrals of such patients to pulmonology. METHODS AND RESULTS: A task force comprising an equal number of cardiologists and pulmonologists met virtually and identified the gaps in current practices for diagnosing patients with comorbid COPD and CVD in the UAE. The task force has proposed an algorithm to expedite the referral of CVD patients suspected of COPD from cardiology to pulmonology. CONCLUSION: Implementing this referral algorithm across all cardiology departments in the UAE can facilitate the diagnosis of COPD in CVD patients, allow timely treatment of COPD, and improve patient outcomes.

摘要

引言:慢性阻塞性肺疾病(COPD)与心血管疾病(CVD)并存的情况极为普遍,会增加住院、发病和死亡风险,并给医疗系统带来巨大经济负担。由于这两种疾病的风险因素和症状存在重叠,因此对合并CVD的患者进行COPD诊断以及反之对合并COPD的患者进行CVD诊断都具有挑战性。这个由肺科医生和心脏病专家组成的8人特别工作组一致认为,在阿联酋,虽然疑似患有CVD的COPD患者会被迅速转诊至心脏病科,但可能同时患有COPD的CVD患者往往不会被转诊,或者从心脏病科转诊至肺科的时间较晚。必须解决在识别可能同时患有COPD的CVD患者方面的这一差距,以便将此类患者转诊至肺科。 方法与结果:一个由同等数量的心脏病专家和肺科医生组成的特别工作组进行了线上会议,确定了阿联酋目前诊断合并COPD和CVD患者的实践中的差距。该特别工作组提出了一种算法,以加快将疑似患有COPD的CVD患者从心脏病科转诊至肺科的速度。 结论:在阿联酋所有心脏病科实施这种转诊算法,可以促进对CVD患者的COPD诊断,实现对COPD的及时治疗,并改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e53/12235745/a7ebdbd14784/fcvm-12-1531966-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e53/12235745/0a193cfaf107/fcvm-12-1531966-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e53/12235745/c1b19acd630f/fcvm-12-1531966-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e53/12235745/28d266ed0ce0/fcvm-12-1531966-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e53/12235745/ff12248d2e2e/fcvm-12-1531966-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e53/12235745/a7ebdbd14784/fcvm-12-1531966-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e53/12235745/0a193cfaf107/fcvm-12-1531966-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e53/12235745/c1b19acd630f/fcvm-12-1531966-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e53/12235745/28d266ed0ce0/fcvm-12-1531966-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e53/12235745/ff12248d2e2e/fcvm-12-1531966-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e53/12235745/a7ebdbd14784/fcvm-12-1531966-g005.jpg

相似文献

[1]
Streamlining referrals by establishing a UAE-specific referral algorithm for CVD patients with overlapping COPD: a collaborative effort by cardiologists and pulmonologists.

Front Cardiovasc Med. 2025-6-24

[2]
The Black Book of Psychotropic Dosing and Monitoring.

Psychopharmacol Bull. 2024-7-8

[3]
Management of urinary stones by experts in stone disease (ESD 2025).

Arch Ital Urol Androl. 2025-6-30

[4]
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.

Clin Orthop Relat Res. 2025-1-1

[5]
Clinical Practice Updates: AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.

Clin Gastroenterol Hepatol. 2025-5-19

[6]
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.

Cochrane Database Syst Rev. 2022-2-24

[7]
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).

Cochrane Database Syst Rev. 2021-7-20

[8]
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Cochrane Database Syst Rev. 2022-5-20

[9]
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.

Cochrane Database Syst Rev. 2017-5-23

[10]
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.

Clin Orthop Relat Res. 2024-12-1

本文引用的文献

[1]
Is 'Cardiopulmonary' the New 'Cardiometabolic'? Making a Case for Systems Change in COPD.

Pulm Ther. 2024-12

[2]
Incidental Findings in Lung Cancer Screening.

Cancers (Basel). 2024-7-20

[3]
Prevalence and Management of Chronic Obstructive Pulmonary Disease in the Gulf Countries with a Focus on Inhaled Pharmacotherapy.

J Aerosol Med Pulm Drug Deliv. 2024-8

[4]
Can blood eosinophil count be used as a predictive marker for the severity of COPD and concomitant cardiovascular disease? The relationship with the 2023 Version of the Global Initiative for Chronic Obstructive Lung Disease Staging.

Eur Rev Med Pharmacol Sci. 2024-4

[5]
Cardiovascular disease and risk in COPD: a state of the art review.

Expert Rev Cardiovasc Ther. 2024

[6]
Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease.

Arch Bronconeumol. 2024-4

[7]
QRISK3 underestimates the risk of cardiovascular events in patients with COPD.

Thorax. 2024-7-16

[8]
Management of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Hospitalized Patients From Admission to Discharge: A Comprehensive Review of Therapeutic Interventions.

Cureus. 2023-8-18

[9]
Association between chronic obstructive pulmonary disease and cardiovascular disease in adults aged 40 years and above: data from NHANES 2013-2018.

BMC Pulm Med. 2023-8-31

[10]
The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study.

Lancet Glob Health. 2023-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索